Clinical Trial Update: A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection [Phase 2]

View source ↗

Summary

A Phase 2a study evaluating the viral kinetics and safety of telaprevir in participants with genotype 2 or 3 hepatitis C infection is completed, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Telaprevir (telaprevir)

Snippet

Sponsor: Tibotec BVBA | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2013-06-04